309 related articles for article (PubMed ID: 27372215)
1. Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.
Carriere N; Bourriez JL; Delval A; Derambure P; Defebvre L; Dujardin K
J Parkinsons Dis; 2016 Jun; 6(3):651-66. PubMed ID: 27372215
[TBL] [Abstract][Full Text] [Related]
2. Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.
Spay C; Meyer G; Lio G; Pezzoli G; Ballanger B; Cilia R; Boulinguez P
Clin Neurophysiol; 2019 Nov; 130(11):2065-2075. PubMed ID: 31541984
[TBL] [Abstract][Full Text] [Related]
3. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
[TBL] [Abstract][Full Text] [Related]
4. Impulse control disorders in Parkinson's disease.
Weintraub D; Potenza MN
Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
[TBL] [Abstract][Full Text] [Related]
5. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
6. Executive functioning and risk-taking behavior in Parkinson's disease patients with impulse control disorders.
Pineau F; Roze E; Lacomblez L; Bonnet AM; Vidailhet M; Czernecki V; Corvol JC
J Neural Transm (Vienna); 2016 Jun; 123(6):573-81. PubMed ID: 27085342
[TBL] [Abstract][Full Text] [Related]
7. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
8. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.
Pellicano C; Niccolini F; Wu K; O'Sullivan SS; Lawrence AD; Lees AJ; Piccini P; Politis M
J Neurol; 2015 Dec; 262(12):2653-61. PubMed ID: 26410743
[TBL] [Abstract][Full Text] [Related]
9. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic influences on risk preferences of Parkinson's disease patients.
Kobayashi S; Asano K; Matsuda N; Ugawa Y
Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
[TBL] [Abstract][Full Text] [Related]
11. Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.
Tessitore A; Santangelo G; De Micco R; Vitale C; Giordano A; Raimo S; Corbo D; Amboni M; Barone P; Tedeschi G
Parkinsonism Relat Disord; 2016 Mar; 24():119-25. PubMed ID: 26810913
[TBL] [Abstract][Full Text] [Related]
12. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.
Ray N; Strafella AP
Clin EEG Neurosci; 2010 Apr; 41(2):87-93. PubMed ID: 20521491
[TBL] [Abstract][Full Text] [Related]
13. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
[TBL] [Abstract][Full Text] [Related]
14. Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience.
Bugalho P; Oliveira-Maia AJ
Behav Neurol; 2013 Jan; 27(4):547-57. PubMed ID: 23242359
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.
Aracil-Bolaños I; Strafella AP
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S101-5. PubMed ID: 26298389
[TBL] [Abstract][Full Text] [Related]
17. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
18. Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing.
Meyer GM; Spay C; Laurencin C; Ballanger B; Sescousse G; Boulinguez P
Neurosci Biobehav Rev; 2019 Mar; 98():164-176. PubMed ID: 30639672
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders in Parkinson's disease: recent advances.
Voon V; Mehta AR; Hallett M
Curr Opin Neurol; 2011 Aug; 24(4):324-30. PubMed ID: 21725242
[TBL] [Abstract][Full Text] [Related]
20. Prospective cohort study of impulse control disorders in Parkinson's disease.
Bastiaens J; Dorfman BJ; Christos PJ; Nirenberg MJ
Mov Disord; 2013 Mar; 28(3):327-33. PubMed ID: 23283708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
